OBSV - ObsEva - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

8.921M

Cash

9.684M

Avg Qtr Burn

-10.96M

Short % of Float

0.78%

Insider Ownership

2.02%

Institutional Own.

13.42%

Qtr Updated

09/30/22

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Ebopiprant (OBE022) Details Preterm labor	Phase 2b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
YSELTY® (linzagolix) Details Benign tumor	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
YSELTY® (linzagolix) Details Inflammatory disease, Endometriosis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.